经皮蒸发给药系统:从概念到商业产品
Transdermal Evaporation Drug Delivery System: Concept to Commercial Products.
作者信息
Parhi Rabinarayan, Swain Suryakanta
机构信息
GITAM Institute of Pharmacy, GITAM (Deemed to be University), Gandhi Nagar Campus, Rushikonda, Visakhapatnam-530045, Andhra Pradesh, India.
Southern Institute of Medical Sciences, College of Pharmacy, Department of Pharmaceutics, SIMS Group of Institutions, Mangaldas Nagar, Vijyawada Road, Guntur-522 001, Andhra Pradesh, India.
出版信息
Adv Pharm Bull. 2018 Nov;8(4):535-550. doi: 10.15171/apb.2018.063. Epub 2018 Nov 29.
Since two decades or so transdermal route established itself as better alternative to traditional oral route. This is possible due to continuous innovations in transdermal drug delivery (TDD), which not only enables researchers from academia and industry to successfully develop and launch many new pharmaceuticals but also allow to include new classes of drugs that can be developed into transdermal formulations. These successes are achieved due to the use of novel techniques based on either physical or chemical approaches. However, both of these techniques suffer due to their own disadvantages. Comparatively, a simple method of supersaturation to enhance drug permeation across skin has created a new wave of interest. Even though the application supersaturated principle in topical and TDD has been used from 1960s, but proper control of drug release and formation of stable supersaturated states has been the core of intense research in the last decade. Out of various methods used to get supersaturated system, evaporation method is considered as most efficient and practically feasible for TDD. Therefore, in this review concept of supersaturation, selection of solvent system and the mechanism of inhibition of crystallization are discussed. Application of evaporation systems in the development of transdermal formulations such as solutions, semisolids and metered dose therapeutic systems (MDTS) and the commercial evaporative systems are also discussed in this review.
大约二十年来,经皮给药途径已成为传统口服给药途径的更好替代方案。这得益于经皮给药(TDD)的不断创新,这不仅使学术界和工业界的研究人员能够成功开发并推出许多新药物,还能纳入可开发成经皮制剂的新类型药物。这些成功得益于基于物理或化学方法的新技术的应用。然而,这两种技术都有其自身的缺点。相比之下,一种通过过饱和来增强药物经皮渗透的简单方法引发了新的关注热潮。尽管过饱和原理在局部给药和经皮给药中的应用自20世纪60年代就已开始,但在过去十年中,对药物释放的适当控制和稳定过饱和状态的形成一直是深入研究的核心。在用于获得过饱和系统的各种方法中,蒸发法被认为是经皮给药最有效且实际可行的方法。因此,本综述讨论了过饱和的概念、溶剂系统的选择以及抑制结晶的机制。本综述还讨论了蒸发系统在经皮制剂(如溶液、半固体和定量给药治疗系统(MDTS))开发中的应用以及商业蒸发系统。